Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Biogen’s aducanumab data impress the media, but not the market
Biogen’s aducanumab data impress the media, but not the market
Biogen’s aducanumab data impress the media, but not the market
Submitted by
admin
on September 1, 2016 - 9:37am
Source:
Fierce Biotech
News Tags:
Biogen
aducanumab
Alzheimer's disease
Headline:
Biogen’s aducanumab data impress the media, but not the market
Do Not Allow Advertisers to Use My Personal information